Glucose-Dependent Insulin Release from Genetically Engineered K Cells

See allHide authors and affiliations

Science  08 Dec 2000:
Vol. 290, Issue 5498, pp. 1959-1962
DOI: 10.1126/science.290.5498.1959

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Genetic engineering of non-β cells to release insulin upon feeding could be a therapeutic modality for patients with diabetes. A tumor-derived K-cell line was induced to produce human insulin by providing the cells with the human insulin gene linked to the 5'-regulatory region of the gene encoding glucose-dependent insulinotropic polypeptide (GIP). Mice expressing this transgene produced human insulin specifically in gut K cells. This insulin protected the mice from developing diabetes and maintained glucose tolerance after destruction of the native insulin-producing β cells.

  • * To whom correspondence should be addressed. E-mail: tim.kieffer{at}

View Full Text

Stay Connected to Science